Filenews 6 January 2026
Neuralink, Elon Musk's neurotechnology company, has announced that it plans to start "high-volume" production of brain-computer interface devices in 2026. In a post on the X platform, Musk said that the company aims to increase their production and proceed with an (almost) fully automated process of implanting them in humans.
The implant (known as "Telepathy") is designed to allow people with severe paralysis (including due to spinal cord injuries) to manipulate digital tools through thinking. The first test participant, who received the implant in January 2024, used it to move the cursor to a laptop, browse the internet, and interact on social media. As he has told Business Insider, technology has helped to enhance his autonomy and make everyday communication easier.
Neuralink began clinical trials in humans in 2024 after previously addressing safety issues raised by the U.S. Food and Drug Administration (FDA). It is recalled that the FDA had initially rejected the company's request in 2022, as reported by Reuters. By September 2025, 12 people with severe paralysis worldwide had received the company's implants and are using them to control digital as well as physical tools through thought.
